{Reference Type}: Journal Article
{Title}: Apical tubular complement activation and the loss of kidney function in proteinuric kidney diseases.
{Author}: Alkaff FF;Lammerts RGM;Daha MR;Berger SP;van den Born J;
{Journal}: Clin Kidney J
{Volume}: 17
{Issue}: 8
{Year}: 2024 Aug
{Factor}: 5.86
{DOI}: 10.1093/ckj/sfae215
{Abstract}: Many kidney diseases are associated with proteinuria. Since proteinuria is independently associated with kidney function loss, anti-proteinuric medication, often in combination with dietary salt restriction, comprises a major cornerstone in the prevention of progressive kidney failure. Nevertheless, complete remission of proteinuria is very difficult to achieve, and most patients with persistent proteinuria slowly progress toward kidney failure. It is well-recognized that proteinuria leads to kidney inflammation and fibrosis via various mechanisms. Among others, complement activation at the apical side of the proximal tubular epithelial cells is suggested to play a crucial role as a cause of progressive loss of kidney function. However, hitherto limited attention is given to the pathophysiological role of tubular complement activation relative to glomerular complement activation. This review aims to summarize the evidence for tubular epithelial complement activation in proteinuric kidney diseases in relation to loss of kidney function.